Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 EUR | -.--% | -.--% | -.--% |
May. 29 | Neovacs: mRNA approach validated in preclinical trial | CF |
May. 27 | Neovacs: collaboration contract with INSERM team | CF |
Performance
3 months | -99.04% |
Volumes
marketsBasic data
Highs and lows
Indicators
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
- Stock Market
- Equities
- ALNEV Stock
- 0LW Stock
- Quotes NEOVACS SA